Logo - springer
Slogan - springer

Medicine - Oncology & Hematology | International Journal of Clinical Oncology

International Journal of Clinical Oncology

International Journal of Clinical Oncology

Editor-in-Chief: Osamu Ogawa

ISSN: 1341-9625 (print version)
ISSN: 1437-7772 (electronic version)

Journal no. 10147

  • 90% of authors who answered a survey reported that they would definitely publish or probably publish in the journal again

The International Journal of Clinical Oncology (IJCO) welcomes original research papers on all aspects of clinical oncology that report the results of novel and timely investigations. Reports on clinical trials are encouraged. Experimental studies will also be accepted if they have obvious relevance to clinical oncology. Membership in the Japan Society of Clinical Oncology is not a prerequisite for submission to the journal. Papers are received on the understanding that: their contents have not been published in whole or in part elsewhere; that they are subject to peer review by at least two referees and the Editors, and to editorial revision of the language and contents; and that the Editors are responsible for their acceptance, rejection, and order of publication.

Related subjects » Cancer Research - Oncology & Hematology

Impact Factor: 2.17 (2013) * 

Journal Citation Reports®, Thomson Reuters

Abstracted/Indexed in 

Science Citation Index Expanded (SciSearch), Journal Citation Reports/Science Edition, PubMed/Medline, SCOPUS, EMBASE, Chemical Abstracts Service (CAS), Google Scholar, EBSCO, CSA, Academic OneFile, Academic Search, CSA Environmental Sciences, Gale, Health Reference Center Academic, Index to Scienctific & Technical Proceedings, INIS Atomindex, OCLC, SCImago, Summon by ProQuest

Popular Content within this publication 

 

Articles

For authors and editors


  • Journal Citation Reports®, Thomson Reuters
    2013 Impact Factor
  • 2.170
  • Aims and Scope

    Aims and Scope

    Close

    The International Journal of Clinical Oncology (IJCO) welcomes original research papers on all aspects of clinical oncology that report the results of novel and timely investigations. Reports on clinical trials are encouraged. Experimental studies will also be accepted if they have obvious relevance to clinical oncology. Membership in the Japan Society of Clinical Oncology is not a prerequisite for submission to the journal. Papers are received on the understanding that: their contents have not been published in whole or in part elsewhere; that they are subject to peer review by at least two referees and the Editors, and to editorial revision of the language and contents; and that the Editors are responsible for their acceptance, rejection, and order of publication.

  • Submit Online
  • Instructions for authors

    Instructions for Authors

    Close

  • Certification Form (pdf, 81 kB)
  • Conflict of Interest Disclosure Statemen...
  • English Language Editing

    English Language Editing

    Close

  • Author Academy: Training for Authors
  • Copyright information

    Copyright information

    Close

    Submission of a manuscript implies: that the work described has not been published before (except in the form of an abstract or as part of a published lecture, review, or thesis); that it is not under consideration for publication elsewhere; that its publication has been approved by all coauthors, if any, as well as by the responsible authorities at the institute where the work has been carried out; that, if and when the manuscript is accepted for publication, the authors agree to automatic transfer of the copyright to the publisher, and that the manuscript will not be published elsewhere in any language without the consent of the copyright holders.

    All articles published in this journal are protected by copyright, which covers the exclusive rights to reproduce and distribute the article (e.g., as offprints), as well as all translation rights. No material published in this journal may be reproduced photographically or stored on microfilm, in electronic data bases, video disks, etc., without first obtaining written permission from the Japan Society of Clinical Oncology.

    The use of general descriptive names, trade names, trademarks, etc., in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.
    While the advice and information in this journal is believed to be true and accurate at the date of its going to press, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may be made. The publisher makes no warranty, express or implied, with respect to the material contained herein.

    Special regulations for photocopies

    To photocopy any work from this publication, permission must be obtained from the following organization, which has been delegated by the copyright owner for copyright clearance (expect in the USA, for which, see below): Japan Academic Association for Copyright Clearance (JAACC), 6-41 Akasaka 9-chome, Minato-ku, Tokyo 107-0052, Japan. Telephone: +81-3-3475-5618; Fax: +81-3-3475-5619; E-mail: jaacc@mtd.biglobe.ne.jp. In the USA: Photocopies may be made for personal or in-house use beyond the limitations stipulated under Section 107 or 108 of US. Copyright Law, provided a fee is paid. All fees should be paid to the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923, USA, Telephone: +1-978-750-8400; Fax: +1-978-646-8600, stating the ISSN number, the volume, and the first and last page numbers of each article copied. The copyright owner's consent does not include copying for general distribution, promotion, new works, or resale. In these cases, specific written permission must first be obtained from the society.

    © The Japan Society of Clinical Oncology

Alerts for this journal

 

Get the table of contents of every new issue published in International Journal of Clinical Oncology.